Literature DB >> 20694973

Combination of enzymes and flow perfusion conditions improves osteogenic differentiation of bone marrow stromal cells cultured upon starch/poly(epsilon-caprolactone) fiber meshes.

Ana M Martins1, Anita Saraf, Rui A Sousa, Catarina M Alves, Antonios G Mikos, F Kurtis Kasper, Rui L Reis.   

Abstract

Previous studies have shown that alpha-amylase and lipase are capable of enhancing the degradation of fiber meshes blends of starch and poly(epsilon-caprolactone) (SPCL) under dynamic conditions, and consequently to promote the proliferation and osteogenic differentiation of bone marrow stromal cells (MSCs). This study investigated the effect of flow perfusion bioreactor culture in combination with enzymes on the osteogenic differentiation of MSCs. SPCL fiber meshes were seeded with MSCs and cultured with osteogenic medium supplemented with alpha-amylase, lipase, or a combination of the two for 8 or 16 days using static or flow conditions. Lipase and its combination with alpha-amylase enhanced cell proliferation after 16 days. In addition, the flow perfusion culture enhanced the infiltration of cells and facilitated greater distribution of extracellular matrix (ECM) throughout the scaffolds in the presence/absence of enzymes. A significant amount of calcium was detected after 16 days in all groups cultured in flow conditions compared with static cultures. Nevertheless, when alpha-amylase and lipase were included in the flow perfusion cultures, the calcium content was 379 +/- 30 microg/scaffold after as few as 8 days. The highest calcium content (1271 +/- 32 microg/scaffold) was obtained for SPCL/cell constructs cultured for 16 days in the presence of lipase and flow. Furthermore, von Kossa staining and tetracycline fluorescence of histological sections demonstrated mineral deposition within the scaffolds for all groups cultured for 16 days under flow. However, all the data corroborate that lipase coupled with flow perfusion conditions improve the osteogenic differentiation of MSCs and enhance ECM mineralization. (c) 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694973     DOI: 10.1002/jbm.a.32785

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  5 in total

Review 1.  Biomaterials to prevascularize engineered tissues.

Authors:  Lei Tian; Steven C George
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

2.  Sequential application of steady and pulsatile medium perfusion enhanced the formation of engineered bone.

Authors:  Cristina Correia; Sarindr Bhumiratana; Rui A Sousa; Rui L Reis; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part A       Date:  2013-01-31       Impact factor: 3.845

3.  Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assembly.

Authors:  Serena Danti; Lorenzo Pio Serino; Delfo D'Alessandro; Stefania Moscato; Sabrina Danti; Luisa Trombi; Dinuccio Dinucci; Federica Chiellini; Andrea Pietrabissa; Michele Lisanti; Stefano Berrettini; Mario Petrini
Journal:  Tissue Eng Part C Methods       Date:  2013-04-30       Impact factor: 3.056

4.  Scaffold/Extracellular matrix hybrid constructs for bone-tissue engineering.

Authors:  Richard A Thibault; Antonios G Mikos; F Kurtis Kasper
Journal:  Adv Healthc Mater       Date:  2012-09-28       Impact factor: 9.933

5.  Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Sana Mohiuddin; Dhruva K Mishra; Min P Kim; Joseph A Ludwig; Sandhya Krishnan; Alejandra Ruiz Velasco; Amelia M Vetter; Kristi Pence; David McCall; Danh D Truong; Branko Cuglievan; Brian A Menegaz; Budi Utama; Najat C Daw; Eric R Molina; Rafal J Zielinski; John A Livingston; Richard Gorlick; Antonios G Mikos
Journal:  Cancer Gene Ther       Date:  2021-01-06       Impact factor: 5.987

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.